U.S. federal trademark · Serial No. 98055522
Design, development, and implementation of software for innovators to predict asset values, determine pricing, evidence-generation, and contracting by utilizing a pricing and generalized value module and commercial due diligence module; platform for building recommendations based on clinical evidence of benefit and risk; platform which expedites value assessment and provides qualitative, evidence based approach to support decisions about pricing, evidence generation and contracting.; Providing an interactive website featuring technology that allows users to enter, access, and synthesize information and generate reports for use in consulting with executives and businesses; Software as a service (SAAS) services featuring software for predicting business asset values, determining pricing, evidence-generation, and contracting by utilizing a pricing and generalized value module and commercial due diligence module
Computer software platforms, downloadable, for innovators to predict asset values, determine pricing, evidence-generation, and contracting by utilizing a pricing and generalized value module and commercial due diligence module; Computer software platforms, downloadable, for simulating, forecasting, and analyzing product value, pricing, clinical effectiveness, and commercial viability of medical treatments; Computer software platforms, downloadable, for supporting payer engagement, value-based care strategies, and evidence-generation planning.
Design, development, and implementation of software for innovators to predict asset values, determine pricing, evidence-generation, and contracting by utilizing a pricing and generalized value module and commercial due diligence module; Providing online non-downloadable computer software platforms for simulating and analyzing clinical and commercial scenarios to support drug pricing, value assessment, evidence generation, and payer engagement in the healthcare and biopharmaceutical industries; Providing an interactive website featuring technology that allows users to enter, access, and synthesize information and generate reports for use in consulting with executives and businesses; Software as a service (SAAS) services featuring software for predicting business asset values, determining pricing, evidence-generation, and contracting by utilizing a pricing and generalized value module and commercial due diligence module.
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.